P. Baker

发表

Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides

N. Qureshi, K. Takayama, P. Baker, 1990, Infection and immunity.

Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone

J. Hiernaux, C. Bona, P. Baker, 1981, The Journal of experimental medicine.

CD4+ T cells regulate the magnitude of the antibody response to several helper T cell independent antigens.

R. Buller, P. Baker, P. Stashak, 1991, Immunobiology.

REGULATION OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE

P. Baker, P. Stashak, D. F. Amsbaugh, 1973, The Journal of experimental medicine.

Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides

U. Zähringer, K. Takayama, P. Baker, 1994, Infection and immunity.

Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice

J. Hiernaux, P. Baker, P. Stashak, 1989, Infection and immunity.

A Species–Specific Monoclonal Antibody to Cynodon dactylon

P. Baker, E. Tovey, U. Løvborg, 1998, International Archives of Allergy and Immunology.

Antibiotics as Anti-inflammatory and Immunomodulatory Agents Edited by Bruce K. Rubin and Jun Tamaoki Boston: Birkhäuser Verlag, 2005 273 pp. $159.00 (cloth)

P. Baker, 2005 .

Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide

P. Baker, C. Taylor, P. Stashak, 1983, The Journal of experimental medicine.

Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.

P. Baker, P. Stashak, D. F. Amsbaugh, 1974, Journal of immunology.

Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.

P. Baker, P. Stashak, R. Barth, 1970, Journal of immunology.

Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

P. Baker, P. Stashak, B. Prescott, 1969, Applied microbiology.

Characterization of the immunodeficiency of RIIS/J [corrected] mice. I. Association with the CD5 (LY-1) [corrected] B cell lineage.

J. Hiernaux, P. Baker, P. Stashak, 1989, Journal of immunology.

T cells regulate the IgM antibody response of BALB/c mice to dextran B1355.

P. Baker, C. Taylor, P. Stashak, 1990, Immunobiology.

Brevity of the inductive phase in the immune response of mice to capsular polysaccharide antigens.

P. Baker, M. Landy, 1967, Journal of immunology.

Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.

P. Baker, P. Stashak, D. F. Amsbaugh, 1981, Reviews of infectious diseases.

Homeostatic Control of Antibody Responses: A Model Based on the Recognition of Cell‐Associated Antibody by Regulatory T Cells

P. Baker, 1975, Transplantation reviews.

THE ROLE OF SUPPRESSOR T CELLS IN THE DEVELOPMENT OF LOW-DOSE PARALYSIS TO TYPE III PNEUMOCOCCAL POLYSACCARIDE

P. Baker, P. Stashak, W. Burns, 1974 .

Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.

P. Baker, P. Stashak, D. F. Amsbaugh, 1973, The Journal of experimental medicine.

Strain differences in the ability of antithymocyte serum (ATS) to enhance the antibody response of inbred mice to type 3 pneumococcal polysaccharide.

P. Baker, P. Stashak, D. F. Amsbaugh, 1973, Cellular immunology.

Analysis of the optimal conditions for the adsorption of type III pneumococcal polysaccharide to plastic for use in solid-phase ELISA.

P. Baker, P. Stashak, K. Elkins, 1990, Journal of immunological methods.

Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.

P. Baker, P. Stashak, D. F. Amsbaugh, 1982, Journal of immunology.

SUSCEPTIBILITY OF (CBA/N X DBA/2)F1 MALE MICE TO INFECTION WITH TYPE 3 STREPTOCOCCUS PNEUMONIAE

D. Briles, M. Nahm, P. Baker, 1980 .

Adjuvanticity of pertussis toxin is mediated by differential effects on the activity of T suppressor, T amplifier and T helper cells.

P. Baker, K. Hasløv, J. W. Petersen, 1991, Immunobiology.

BDPA-Doped Polystyrene Beads as Polarization Agents for DNP-NMR.

Yunzhi Zhang, P. Baker, L. Casabianca, 2016, The journal of physical chemistry. B.

The role of antigen in the activation of regulatory T cells by immune B cells.

P. Baker, C. Taylor, P. Stashak, 1985, Cellular immunology.

T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications.

P. Baker, 1992, The Journal of infectious diseases.

Luminal microvesicles uniquely influence translocating bacteria after SIV infection.

J. Brenchley, N. Altan-Bonnet, T. Nutman, 2021, Mucosal Immunology.

IMMUNOLOGICAL PARALYSIS TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE AS ASSESSED BY AN IMMUNO‐PLAQUE PROCEDURE

P. Baker, P. Stashak, R. Barth, 1971 .

Effects of IL-4 depletion on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice.

P. Baker, C. Taylor, P. Stashak, 1993, Immunobiology.

Characterization of the immunodeficiency of RIIIS/J mice: immune response to polysaccharide antigens

J. Hiernaux, P. Baker, P. Stashak, 1990, Infection and immunity.

Butyrate administration is not sufficient to improve immune reconstitution in antiretroviral-treated SIV-infected macaques

J. Brenchley, P. Baker, H. Hickman, 2022, Scientific Reports.

Effect of endotoxin on suppressor T cell function.

P. Baker, 1993, Immunobiology.

Bacterial polysaccharides, endotoxins, and immunomodulation.

P. Baker, C. Taylor, F. S. Ekwunife, 1992, Advances in experimental medicine and biology.

Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A

P. Baker, P. Stashak, M. Fauntleroy, 1990, Infection and immunity.

Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A

J. Hiernaux, P. Baker, M. Fauntleroy, 1988, Infection and immunity.

Ability of monophosphoryl lipid A to augment the antibody response of young mice

J. Hiernaux, P. Baker, P. Stashak, 1988, Infection and immunity.

Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A

P. Baker, C. Taylor, F. Esquivel, 1991, Infection and immunity.

Study of the idiotypy of lipopolysaccharide‐specific polyclonal and monoclonal antibodies

J. Hiernaux, C. Bona, P. Baker, 1982, European journal of immunology.

Lyme borreliosis : the challenge of accuracy 3

J. Halperin, E. Shapiro, G. Wormser, 2012 .

Increased amplifier T cell activity in autoimmune NZB mice and its possible significance in the expression of autoimmune disease.

P. Baker, P. Stashak, M. Fauntleroy, 1986, Immunobiology.

Autoimmune Disease in New Zealand Mice

T. Malek, P. Baker, K. McCoy, 1987 .

Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

P. Baker, P. Stashak, C. Hansen, 1972, The Journal of experimental medicine.

Microbial Infections

C. E. Taylor, P. Baker, F. S. Ekwunife, 1992, Advances in Experimental Medicine and Biology.

Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.

P. Baker, P. Stashak, R. Barth, 1970, Journal of immunology.

Nonspecific and Candida‐Specific Immune Responses in Mice Suppressed by Chronic Administration of Anti‐μ

P. Baker, U. Kuruganti, L. Henderson, 1988, Journal of leukocyte biology.

Modulation of immune responses by surface polysaccharides of Candida albicans.

D. Ennist, P. Baker, K. Elkins, 1988, Reviews of infectious diseases.

GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE

P. Baker, P. Stashak, R. Asofsky, 1974, The Journal of Experimental Medicine.

GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE

P. Baker, P. Stashak, C. Hansen, 1972, The Journal of experimental medicine.

Use of the periodate oxidation coupling method for the detection of antibody and antibody-producing cells specific for staphylococcal lipoteichoic acid.

P. Baker, P. Beining, B. Prescott, 1980, Journal of immunological methods.

Generation of anti-type III pneumococcal polysaccharide hybridomas from mice with an X-linked B-lymphocyte defect

P. Baker, K. J. Kim, B. Prescott, 1979, The Journal of experimental medicine.

Chemical Composition and Biological Properties of the Endotoxin of Brucella abortus

P. Baker, J. Wilson, 1965, Journal of bacteriology.

Hypoferremia in Mice and Its Application to the Bioassay of Endotoxin

P. Baker, J. Wilson, 1965, Journal of bacteriology.

Increased activation of antigen-primed or memory B cells by bacterial lipopolysaccharide.

P. Baker, M. Fauntleroy, J. Rudbach, 1987, Cellular immunology.

Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid

P. Baker, P. Beining, B. Prescott, 1980, Infection and immunity.

Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae

D. Briles, M. Nahm, J. Kearney, 1981, The Journal of experimental medicine.

Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components.

P. Baker, P. Stashak, K. Elkins, 1986, Cellular immunology.

Immunosuppressive effects induced by the polysaccharide moiety of some bacterial lipopolysaccharides.

K. Takayama, P. Baker, C. Taylor, 1992, Immunobiology.

Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity

A. Hasegawa, S. Kusumoto, N. Qureshi, 1992, Infection and immunity.

Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice

P. Baker, C. Taylor, P. Stashak, 1991, Infection and Immunity.

Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines

P. Baker, C. Taylor, P. Stashak, 1991, Infection and immunity.

Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes

P. Baker, 1990, Infection and immunity.

Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide.

P. Baker, C. Taylor, P. Stashak, 1983, Journal of Immunology.

Effect of splenectomy on the expression of regulatory T cell activity.

P. Baker, D. F. Amsbaugh, B. Prescott, 1978, Journal of immunology.

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.

P. Baker, P. Stashak, D. F. Amsbaugh, 1971, Immunology.

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

P. Baker, P. Stashak, D. F. Amsbaugh, 1971, Immunology.

Quantitative and Qualitative Studies on the Primary Antibody Response to Pneumococcal Polysaccharides at the Cellular Level

P. Baker, P. Stashak, 1969, The Journal of Immunology.

Effects of interferon gamma on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice.

P. Baker, C. Taylor, P. Stashak, 1994, Immunobiology.

The influence of monophosphoryl lipid A (MPL) on erythrocyte autoantibody formation.

P. Baker, C. Taylor, P. Stashak, 1993, Immunobiology.

Metabolic activity is necessary for activation of T suppressor cells by B cells.

P. Baker, P. Stashak, K. Elkins, 1990, Journal of immunology.

Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide

J. Hiernaux, P. Baker, P. Stashak, 1989, Infection and immunity.

Examination of the differential characteristics of amplifier and contrasuppressor T cells.

P. Baker, M. Fauntleroy, B. Prescott, 1988, Immunobiology.

Prior exposure to subimmunogenic amounts of some bacterial lipopolysaccharides induces specific immunological unresponsiveness

P. Baker, P. Stashak, K. Elkins, 1987, Infection and immunity.

Mechanisms of specific immunological unresponsiveness to bacterial lipopolysaccharides

P. Baker, P. Stashak, K. Elkins, 1987, Infection and immunity.

Transferred B cells from autoimmune NZB/N mice fail to activate T suppressor cells.

P. Baker, P. Stashak, K. Elkins, 1987, Cellular immunology.

Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.

P. Baker, P. Stashak, K. McCoy, 1985, Journal of immunology.

Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.

W. Leiserson, P. Baker, C. Taylor, 1984, Journal of immunology.

Sensitivity of amplifier T cells involved in the antibody response to type III pneumococcal polysaccharide to anti-lymphocyte serum.

P. Baker, P. Stashak, R. Markham, 1977, Journal of immunology.

Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.

P. Baker, P. Stashak, R. Markham, 1977, Journal of immunology.

Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.

D. Alling, P. Baker, P. Stashak, 1976, Journal of immunology.

Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.

P. Baker, P. Stashak, H. Morse, 1976, Journal of immunology.

Lipopolysaccharidelike immunological properties of cell wall glycoproteins isolated from Cytophaga johnsonae

K. Takayama, P. Baker, C. Taylor, 1991, Infection and immunity.

Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein

D. Ennist, P. Baker, P. Stashak, 1987, Infection and immunity.

Cyclic expression of low-dose paralysis.

P. Baker, C. Taylor, P. Stashak, 1983, Cellular immunology.

Specificity of Suppressor T Cells Activated During the Immune Response to Type III Pneumococcal Polysaccharide

P. Baker, P. Stashak, D. F. Amsbaugh, 1981 .

Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III

P. Baker, R. Asofsky, V. Pasanen, 1979, The Journal of experimental medicine.

SYNTHESIS OF TWO CLASSES OF ANTIBODY, yM AND 7(; OR ),M AND ),A, BY IDENTICAL CELLS Amplification of the Antibody Response to Pneumococcal Polysaccharide Type III

P. Baker, R. Asofsky, V. Pasanen, 1979 .

GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE

P. Baker, P. Stashak, D. F. Amsbaugh, 1976, Journal of immunogenetics.

GENETIC CONTROL OF T H E ANTIBODY RESPONSE TO TYPE II I PNEUMOCOCCAL POLYSACCHARIDE IN MICE II. RELATIONSHIP BETWeeN IgM IMMUNOGLOBULIN L~.v~.I,S AND THE ABILITY TO GIVE AN IgM ANTIBODY RESPONSE BY DIANA

P. Baker, P. Stashak, R. Asofsky, 2022 .

Lectin-induced modulation of the antibody response to type III pneumococcal polysaccharide.

P. Baker, C. Taylor, P. Stashak, 1984, Cellular immunology.

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

P. Baker, P. Stashak, D. F. Amsbaugh, 1971, Journal of immunology.

Genes on different chromosomes influence the antibody response to bacterial antigens

P. Baker, P. Stashak, M. Fauntleroy, 2004, Immunogenetics.

Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigens

P. Baker, P. Stashak, J. Rudbach, 1984, Infection and immunity.

Maturation of regulatory factors influencing magnitude of antibody response to capsular polysaccharide of type III Streptococcus pneumoniae.

P. Baker, P. Stashak, H. Morse, 1977, The Journal of infectious diseases.

Specific immunological unresponsiveness to bacterial lipopolysaccharides develops in a cyclic manner

P. Baker, P. Stashak, K. Elkins, 1989, Infection and immunity.

Cyclic development of immunological memory to bacterial lipopolysaccharide

J. Hiernaux, P. Baker, P. Stashak, 1985, Infection and immunity.

Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen

J. Hiernaux, P. Baker, F. Rollwagen, 1983, The Journal of experimental medicine.

Modulation of the immune response to lipopolysaccharide.

C. DeLisi, J. Hiernaux, P. Baker, 1982, Journal of immunology.

Lack of involvement of auto-anti-idiotypic antibody in the regulation of oscillations and tolerance in the antibody response to levan.

C. DeLisi, J. Hiernaux, P. Baker, 1982, Cellular immunology.

Characterization of the Antibody Response to Type III Pneumococcal Polysaccharide at the Cellular Level

P. Baker, P. Stashak, D. F. Amsbaugh, 1971, The Journal of Immunology.

Treatment trials for post-Lyme disease symptoms revisited.

J. Halperin, R. Dattwyler, E. Shapiro, 2013, The American journal of medicine.

Common misconceptions about Lyme disease.

J. Halperin, G. Wormser, P. Baker, 2013, The American journal of medicine.

Unorthodox alternative therapies marketed to treat Lyme disease.

J. Halperin, E. Shapiro, G. Wormser, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lyme borreliosis: the challenge of accuracy.

J. Halperin, E. Shapiro, G. Wormser, 2012, The Netherlands journal of medicine.

Lyme disease: The great controversy

J. Halperin, G. Wormser, P. Baker, 2011 .

Is It Possible to Make a Correct Diagnosis of Lyme Disease on Symptoms Alone? Review of Key Issues and Public Health Implications.

P. Baker, 2019, The American journal of medicine.

Straight Talk About Chronic Lyme Disease.

P. Baker, 2017, The American journal of medicine.

Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

P. Baker, P. Stashak, D. F. Amsbaugh, 1974, Journal of immunology.

The serum antibody response to bacteriophage phi chi 174 in germ-free and conventionally reared mice. I. Assay of neutralizing antibody by a 50 per cent neutralization method.

P. Baker, P. Stashak, B. S. Roberson, 1970, Immunology.

Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response.

P. Baker, P. Stashak, R. Asofsky, 1974, The Journal of experimental medicine.

Experimental bacterial dysbiosis with consequent immune alterations increase intrarectal SIV acquisition susceptibility

Y. Belkaid, J. Brenchley, C. Fennessey, 2023, Cell reports.

Selective sensitivity to hydrocortisone of regulatory functions that determine the magnitude of the antibody response to type III pneumococcal polysaccharide.

P. Baker, P. Stashak, R. Markham, 1978, Journal of immunology.

Characterization of the Immunodeficiency of RIIS/J mice. I. Association with the CD5 (LY-1) B cell lineage

J. Hiernaux, P. Baker, P. Stashak, 1989, Journal of Immunology.

RIIIS/J mice lack a gene influencing the capacity to make an antibody response to helper T cell-independent antigens.

J. Hiernaux, P. Baker, F. Rollwagen, 1982, Journal of Immunology.

Detection and enumeration of antibody-producing cells by specific adherence of antigen-coated bentonite particles.

P. Baker, M. Landy, V. Pasanen, 1966, Journal of immunology.

Modulation of Immune Responses by Surface Polysaccharides

D. Ennist, P. Baker, K. Elkins, 1988 .

False and Misleading Information About Lyme Disease.

E. Shapiro, G. Wormser, P. Baker, 2017, The American journal of medicine.

Perspectives on "chronic Lyme disease".

P. Baker, 2008, The American journal of medicine.

Generation of low-dose paralysis in the absence of the ability to secrete antibody.

P. Baker, P. Stashak, R. Markham, 1978, Journal of Immunology.

Cytodynamics of the distinctive immune response produced in regional lymph nodes by Salmonella somatic polysaccharide.

P. Baker, M. Landy, 1966, Journal of immunology.

Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design.

E. Shapiro, G. Wormser, I. Schwartz, 2012, Vector borne and zoonotic diseases.

Immune responses to Haemophilus influenzae type b polysaccharide T cell regulation of the antibody response to bacterial polysaccharide antigens : an examination of some general characteristics and their implications

P. Baker, 1992 .

Pathogenesis of Lyme neuroborreliosis in an animal model of infection.

P. Baker, 2015, The American journal of pathology.

A Review of Antibiotic-Tolerant Persisters and Their Relevance to Post-Treatment Lyme Disease Symptoms.

P. Baker, 2020, The American journal of medicine.

Beating Lyme: Understanding and treating this complex and often misdiagnosed disease.

P. Baker, 2008 .

Perspectives on "chronic Lyme disease".

P. Baker, 2008, American Journal of Medicine.

Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae

D. Briles, M. Nahm, J. Kearney, 1981, The Journal of experimental medicine.

The Clinical Relevance of Studies on Borrelia burgdorferi Persisters.

G. Wormser, P. Baker, 2017, The American journal of medicine.

Cell-associated IgM, but not IgD or I-A/E, is important in the activation of suppressor T cells by antigen-primed B cells.

P. Baker, P. Stashak, K. Elkins, 1987, Journal of immunology.

Use of Erythrocytes Sensitized with Purified Pneumococcal Polysaccharides for the Assay of Antibody and Antibody-producing Cells

P. Baker, P. Stashak, B. Prescott, 1969 .

Regulation of the Antibody Response to Type III Pneumococcal Polysaccharide

P. Baker, P. Stashak, D. F. Amsbaugh, 1974, The Journal of Immunology.

The pain of “chronic Lyme disease”: moving the discourse in a different direction

P. Baker, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Production of soluble suppressor factor by spleen cells from mice immunized with type III pneumococcal polysaccharide.

P. Baker, C. Taylor, 1985, Journal of immunology.